Life Sciences Investors delivered a 40.59% NAV return in 2025, supported by innovation-focused biotechnology. Read the full ...

W hile challenges persist in the short term, there are signs pointing toward long-term growth for life sciences, according to JLL’s 2024 Life Sciences Real Estate Perspective and Cluster Analysis. The ...

The transition from non-life to life was very likely aided by an asteroid hitting Earth, prebiotic chemistry, molecular ...

As the life sciences and Medtech sectors undergo rapid transformation, new priorities are reshaping where companies choose to grow. A new report from the Hickey Institute explores the evolving ...

Caris projects 2026 total revenue in the range of $1.0 billion to $1.02 billion, anticipating molecular profiling growth of approximately 21% to 22%, and therapy selection volume growth of around 20% ...

Delaware has seen a 65% increase in new biotechnology companies over the past decade, according to a recent report by the Delaware BioScience Association and the Delaware Prosperity Partnership. This ...

It's the final day to submit your nominees for this year's Fiercest Women in Life Sciences! The nomination form will close at 11:59 p.m. ET on Friday, Sept. 26. Every year, we celebrate women making a ...

William “Bill” McKeon is the President and Chief Executive Officer of the Texas Medical Center. He is responsible for driving strategic, operational and programmatic initiatives across the Texas ...

Ed Field is President of BioLabs NC. Mr. Field has 20+ years c-level experience in building and selling numerous early-stage and publicly-traded biotechnology companies. He has been responsible for ...

Research shows that women remain woefully underrepresented at the highest levels of leadership in the life sciences industry. Those who have broken through that glass ceiling, however, are not only ...

The $700 million Taystee Lab Building sits in the Manhattanville Factory District, but the laboratory goes beyond West Harlem’s manufacturing history. Surrounded by brick buildings on West 126th ...

Regulators are modernizing their expectations, and it's become clear that validation can no longer function as a point-in-time event.